6595NCM228032: SODIUM PHOSPHATE SOLUTION.
The SODIUM PHOSPHATE SOLUTION is a the manufacturer industrial component. Key specifications include administration: INTRAVENOUS, primary_container_type: VIAL, primary_container_content_quantity: 15.0 MILLILITERS, active_medicament_medicinal_strength: 3.0 MILLIMOLES SODIUM PHOSPHATE EQUIVALENT PER MILLILITER, part_name_assigned_by_controlling_agency: SODIUM PHOSPHATE INTRAVENOUS SOLUTION 3MMOL/ML 15ML VIALS 25 VIAL PER PACKAGE.. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-701-1852, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAVENOUS |
| special_features | SODIUM PHOSPHATE 45MMOL/15ML (3MMOL/ML) INTRAVENOUS SOLUTION 15ML VIALS, 25 VIALS PER PACKAGE. MUST BE DILUTED PRIOR TO ADMINISTRATION; STORE AT 20 TO 25 C (68 TO 77 F) - CONTROLLED ROOM TEMPERATURE. |
| primary_container_type | VIAL |
| primary_container_content_quantity | 15.0 MILLILITERS |
| active_medicament_medicinal_strength | 3.0 MILLIMOLES SODIUM PHOSPHATE EQUIVALENT PER MILLILITER |
| part_name_assigned_by_controlling_agency | SODIUM PHOSPHATE INTRAVENOUS SOLUTION 3MMOL/ML 15ML VIALS 25 VIAL PER PACKAGE. |
| NSN | 6505-01-701-1852 |
| ADMINISTRATION | INTRAVENOUS |
| PRIMARY CONTAINER CONTENT QUANTITY | 15.0 MILLILITERS |
| PRIMARY CONTAINER TYPE | VIAL |
| SPECIAL FEATURES | SODIUM PHOSPHATE 45MMOL/15ML (3MMOL/ML) INTRAVENOUS SOLUTION 15ML VIALS, 25 VIALS PER PACKAGE. MUST BE DILUTED PRIOR TO ADMINISTRATION; STORE AT 20 TO 25 C (68 TO 77 F) - CONTROLLED ROOM TEMPERATURE. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | SODIUM PHOSPHATE INTRAVENOUS SOLUTION 3MMOL/ML 15ML VIALS 25 VIAL PER PACKAGE. |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 3.0 MILLIMOLES SODIUM PHOSPHATE EQUIVALENT PER MILLILITER |